inhibiting MEK increases AKT phosphorylation (in EFGR and HER2 driven cancer cells)
phosphorylated ERBB3 activates PI3K
ERK decreases ERBB tyrosine phosphorylation
PI3K increases AKT activity  
MEK phosphorylates ERK
ERK phosphorylates EGFR
ERK phosphorylates HER2
